The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
Open accessAbstract
BACKGROUND: With the shift of research focus towards the pre-dementia stage of Alzheimer's disease (AD), there is an urgent need for reliable, non-invasive biomarkers to predict amyloid pathology. The aim of this study was to assess whether easily obtainable measures from structural MRI, combined with demographic data, cognitive data and apolipoprotein E (APOE) ε4 genotype, can be used to predict amyloid pathology using machine-learning classification. METHODS: We examined 810 subjects with structural MRI data and amyloid markers from the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery study, including subjects with normal cognition (CN, n = 337, age 66.5 ± 7.2, 50% female, 27% amyloid positive), mild cognitive impairment (MCI, n = 375, age 69.1 ± 7.5, 53% female, 63% amyloid positive) and AD dementia (n = 98, age 67.0 ± 7.7, 48% female, 97% amyloid positive). Structural MRI scans were visually assessed and Freesurfer was used to obtain subcortical volumes, cortical thickness and surface area measures. We first assessed univariate associations between MRI measures and amyloid pathology using mixed models. Next, we developed and tested an automated classifier using demographic, cognitive, MRI and APOE ε4 information to predict amyloid pathology. A support vector machine (SVM) with nested 10-fold cross-validation was applied to identify a set of markers best discriminating between amyloid positive and amyloid negative subjects. RESULTS: In univariate associations, amyloid pathology was associated with lower subcortical volumes and thinner cortex in AD-signature regions in CN and MCI. The multi-variable SVM classifier provided an area under the curve (AUC) of 0.81 ± 0.07 in MCI and an AUC of 0.74 ± 0.08 in CN. In CN, selected features for the classifier included APOE ε4, age, memory scores and several MRI measures such as hippocampus, amygdala and accumbens volumes and cortical thickness in temporal and parahippocampal regions. In MCI, the classifier including demographic and APOE ε4 information did not improve after additionally adding imaging measures. CONCLUSIONS: Amyloid pathology is associated with changes in structural MRI measures in CN and MCI. An automated classifier based on clinical, imaging and APOE ε4 data can identify the presence of amyloid pathology with a moderate level of accuracy. These results could be used in clinical trials to pre-screen subjects for anti-amyloid therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The most common validation processes performed were N-fold cross validation (55)51,52, train test split (51), leave one out cross validation (10), and external dataset (10).”
From Multimodal machine learning in precision health: A scoping review (2022) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538 · cited 1×
“In the adopted treebased feature selection strategy, the Gini index was used to measure the relevance of each feature [37].”
MethodScikit-learn: Machine Learning in Python
Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016
LIBSVM: A library for support vector machines
Chang, C.-C., & Lin, C.-J. (2011) · ACM Transactions on Intelligent Systems and Technology · doi:10.1145/1961189.1961199 · Cited by 40,918
A Tutorial on Support Vector Machines for Pattern Recognition
Burges, C. J. C. (1998) · Data Mining and Knowledge Discovery · doi:10.1023/a:1009715923555 · Cited by 16,429
Fischl, B. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.021 · Cited by 9,526
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging
Fazekas, F., Chawluk, J., Alavi, A., Hurtig, H., & Zimmerman, R. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.2.351 · Cited by 5,334 · cited 1×
“White matter hyperintensities were visually assessed on FLAIR images (n = 812) using the 4-point Fazekas scale (none, punctate, early confluent, confluent) [29].”
MethodScheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Self-citation(2010) · doi:10.5555/1756006.1859921 · Cited by 1,924 · cited 2×
“the classifier works perfectly on the training data, but is poorly generalizable to new data), we performed feature relevance evaluation and dimensionality reduction using a tree-based feature selection approach with a nested 10-fold cross-validation design [35, 36].”
MethodResultScheltens, P., Leys, D., Barkhof, F., Huglo, D., Weinstein, H. C., Vermersch, P., Kuiper, M., Steinling, M., Wolters, E. C., & Valk, J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.10.967 · Cited by 1,784
Self-citationPrevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4668 · Cited by 1,610
Self-citation
Cited by
Multimodal machine learning in precision health: A scoping review
Kline, A., Wang, H., Li, Y., Dennis, S., Hutch, M., Xu, Z., Wang, F., Cheng, F., & Luo, Y. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00712-8 · Cited by 528
“The most common validation processes performed were N-fold cross validation (55)(51,52), train test split (51), leave one out cross validation (10), and external dataset (10).”
MethodVisser, P. J., Reus, L. M., Gobom, J., Jansen, I. E., Dicks, E., van der Lee, S. J., Tsolaki, M., Verhey, F. R. J., Popp, J., Martínez‐Lage, P., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00521-3 · Cited by 100
Self-citationTosun, D., Veitch, D., Aisen, P., Jack, C. R., Jagust, W. J., Petersen, R. C., Saykin, A. J., Bollinger, J., Ovod, V., Mawuenyega, K. G., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab008 · Cited by 79
Self-citationCumplido‐Mayoral, I., García-Prat, M., Operto, G., Falcón, C., Shekari, M., Cacciaglia, R., Milà‐Alomà, M., Lorenzini, L., Ingala, S., Wink, A. M., et al. (2023) · eLife · doi:10.7554/elife.81067 · Cited by 80
Self-citationShi, L., Westwood, S., Baird, A. L., Winchester, L., Dobricic, V., Kilpert, F., Hong, S., Franke, A., Hye, A., Ashton, N. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.06.4951 · Cited by 74
“Genotypes for reconstruction of the APOE ε2/3/4 haplotypes were either generated on the Global Screening Array (rs7412) or by manual genotyping (rs429358) as described previously [31].”
Self-citation
Metadata
- Authors
- ten Kate, M., Redolfi, A., Peira, E., Bos, I., Vos, S. J., Vandenberghe, R., Gabel, S., Schaeverbeke, J., Scheltens, P., Blin, O., Richardson, J. C., Bordet, R., Wallin, A., Eckerstrom, C., Molinuevo, J. L., Engelborghs, S., Van Broeckhoven, C., Martinez-Lage, P., Popp, J., Tsolaki, M., Verhey, F. R. J., Baird, A. L., Legido-Quigley, C., Bertram, L., Dobricic, V., Zetterberg, H., Lovestone, S., Streffer, J., Bianchetti, S., Novak, G. P., Revillard, J., Gordon, M. F., Xie, Z., Wottschel, V., Frisoni, G., Visser, P. J., & Barkhof, F.
- Affiliations
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- Maastricht University (NL)
- Universitair Ziekenhuis Leuven (BE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Assistance Publique Hôpitaux de Marseille (FR)
- GlaxoSmithKline (United Kingdom) (GB)
- University of Gothenburg (SE)
- University of Antwerp (BE)
- Centre Hospitalier Universitaire Vaudois (CH)
- University of Oxford (GB)
- University of Oslo (NO)
- Sahlgrenska University Hospital (SE)
- Teva Pharmaceuticals (United States) (US)
- Pfizer (United States) (US)
- University of Geneva (CH)
- University College London (GB)
- ORCID
- ten Kate, Mara
- Redolfi, Alberto
- Peira, Enrico
- Bos, Isabelle
- Vos, Stephanie J.
- Vandenberghe, Rik
- Schaeverbeke, Jolien
- Scheltens, Philip
- Blin, Olivier
- Richardson, Jill C.
- Wallin, Anders
- Engelborghs, Sebastiaan
- Popp, Julius
- Verhey, Frans R. J.
- Bertram, Lars
- Zetterberg, Henrik
- Lovestone, Simon
- Streffer, Johannes
- Novak, Gerald P.
- Gordon, Mark F.
- Xie, Zhiyong
- Wottschel, Viktor
- Frisoni, Giovanni
- Visser, Pieter Jelle
- Barkhof, Frederik
- Venue
- Alzheimer's Research & Therapy
- Published
- 2018-09-27
- Volume
- 10
- Issue
- 1
- Pages
- 100-100
- ISSN
- 1758-9193 (ISSN-L)
- PMC
- PMC6161396
- OpenAlex
- W2894000069
- Semantic Scholar
- c285a5c2089cbcd3c4a370181672f1ecd2fdb806
- Cited by
- 78
- References
- 52
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 14 · 2023: 9 · 2022: 12 · 2021: 14 · 2020: 7 · 2019: 10
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- Alzheimer s Research & Therapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- IRIS (submittedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Innovative Medicines Initiative Joint Undertaking (EMIF grant: 115372)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- amyloid pathology, Alzheimer's disease, structural MRI, amyloid biomarkers, mild cognitive impairment, pre-dementia, APOE ε4, subcortical volume, cortical thickness, hippocampus, amygdala, accumbens, support vector classifier, multimodal biomarkers, non-invasive prediction, machine learning classification
- MeSH terms
- Aged, Alzheimer Disease, Brain, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, ROC Curve, Biomarkers, Amyloid beta-Peptides, Apolipoprotein E4, Support Vector Machine, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study. https://app.cochat.ai/papers/10.1186/s13195-018-0428-1
- The paper
- ten Kate, M., Redolfi, A., Peira, E., Bos, I., Vos, S. J., Vandenberghe, R., Gabel, S., Schaeverbeke, J., Scheltens, P., Blin, O., Richardson, J. C., Bordet, R., Wallin, A., Eckerstrom, C., Molinuevo, J. L., Engelborghs, S., Van Broeckhoven, C., Martinez-Lage, P., Popp, J., . . . Barkhof, F. (2018). MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study. Alzheimer's Research & Therapy. https://doi.org/10.1186/s13195-018-0428-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.